Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Insmed Inc (INSM)

Insmed Inc (INSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 19,842,082
  • Shares Outstanding, K 189,713
  • Annual Sales, $ 363,710 K
  • Annual Income, $ -913,770 K
  • EBIT $ -976 M
  • EBITDA $ -955 M
  • 60-Month Beta 0.90
  • Price/Sales 53.66
  • Price/Cash Flow N/A
  • Price/Book 188.62

Options Overview Details

View History
  • Implied Volatility 56.41% ( +0.21%)
  • Historical Volatility 79.19%
  • IV Percentile 52%
  • IV Rank 35.88%
  • IV High 92.41% on 04/10/25
  • IV Low 36.27% on 11/06/24
  • Put/Call Vol Ratio 0.68
  • Today's Volume 1,395
  • Volume Avg (30-Day) 3,659
  • Put/Call OI Ratio 1.08
  • Today's Open Interest 91,579
  • Open Int (30-Day) 82,341

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -1.30
  • Number of Estimates 9
  • High Estimate -1.21
  • Low Estimate -1.47
  • Prior Year -1.94
  • Growth Rate Est. (year over year) +32.99%

Price Performance

See More
Period Period Low Period High Performance
1-Month
95.01 +9.64%
on 07/07/25
106.83 -2.49%
on 06/25/25
+3.89 (+3.88%)
since 06/17/25
3-Month
63.81 +63.25%
on 05/08/25
106.83 -2.49%
on 06/25/25
+31.52 (+43.39%)
since 04/17/25
52-Week
60.40 +72.47%
on 04/09/25
106.83 -2.49%
on 06/25/25
+28.63 (+37.90%)
since 07/17/24

Most Recent Stories

More News
Russell Rebalance: 3 Stocks Ready to Move Higher

The Russell reconstitution is underway; here are three stocks that are garnering interest as stocks that could move up to the Russell 1000

KR : 72.22 (+0.43%)
FTAI : 115.65 (+0.43%)
SFM : 169.61 (+1.40%)
HOOD : 105.45 (+2.13%)
INSM : 104.17 (-0.40%)
PLTR : 153.99 (+2.04%)
S&P Futures Tick Lower With Key U.S. Inflation Data in Focus, U.S.-China Trade Talk Details Awaited

June S&P 500 E-Mini futures (ESM25) are trending down -0.14% this morning after the U.S. and China agreed on a framework to ease trade tensions, but investors were left disappointed by the lack of details,...

KLAC : 937.08 (+0.38%)
GTLB : 43.92 (+3.17%)
ORCL : 248.75 (+3.09%)
ESM25 : 6,010.21s (+0.48%)
PLAY : 29.52 (-2.06%)
0QWI.LN : 42.140 (+0.10%)
TSLA : 319.41 (-0.70%)
INTC : 22.80 (+0.48%)
SJM : 108.90 (+1.21%)
CLF : 9.39 (+2.74%)
INSM : 104.17 (-0.40%)
GME : 23.40 (-1.18%)
Stocks Settle Higher on Signs of Progress in US-China Trade Talks

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.55%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.66%. June E-mini S&P...

ADI : 240.97 (+0.15%)
SLB : 34.67 (+0.23%)
TXN : 216.59 (-0.02%)
$IUXX : 23,078.04 (+0.74%)
EGBN : 21.40 (+1.61%)
AUB : 33.40 (+2.96%)
ASML : 744.91 (-1.26%)
RBRK : 86.93 (-0.64%)
DPZ : 468.70 (+0.73%)
ZNU25 : 110-235 (+0.20%)
ESU25 : 6,349.50 (+0.14%)
FANG : 140.93 (+3.27%)
Stocks Supported by Strength in Chip Makers and Energy Producers

The S&P 500 Index ($SPX ) (SPY ) today is up +0.29%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.27%. June E-mini S&P futures (ESM25...

MPC : 174.17 (+1.04%)
CVX : 151.38 (+0.97%)
ADI : 240.97 (+0.15%)
SLB : 34.67 (+0.23%)
TXN : 216.59 (-0.02%)
$IUXX : 23,078.04 (+0.74%)
EGBN : 21.40 (+1.61%)
AUB : 33.40 (+2.96%)
ASML : 744.91 (-1.26%)
RBRK : 86.93 (-0.64%)
DPZ : 468.70 (+0.73%)
ZNU25 : 110-235 (+0.20%)
Stocks Edge Higher as Markets Eye US-China Trade Talks

The S&P 500 Index ($SPX ) (SPY ) today is up +0.21%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.01%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.15%. June E-mini S&P futures (ESM25...

MPC : 174.17 (+1.04%)
CVX : 151.38 (+0.97%)
SLB : 34.67 (+0.23%)
$IUXX : 23,078.04 (+0.74%)
EGBN : 21.40 (+1.61%)
AUB : 33.40 (+2.96%)
RBRK : 86.93 (-0.64%)
DPZ : 468.70 (+0.73%)
ZNU25 : 110-235 (+0.20%)
ESU25 : 6,349.50 (+0.14%)
SJM : 108.90 (+1.21%)
VLO : 144.67 (+1.03%)
Insmed: Q1 Earnings Snapshot

Insmed: Q1 Earnings Snapshot

INSM : 104.17 (-0.40%)
One Vanguard Index Fund to Buy That May Beat the S&P 500 by 100% in the Next Few Years, According to a Wall Street Analyst

Last November, Fundstrat analyst Tom Lee told CNBC that small-cap stocks are headed for a prolonged period of outperformance compared to the large-cap S&P 500 (SNPINDEX: ^GSPC) . "I think small caps could,...

PCVX : 37.37 (+2.19%)
SSB : 97.59 (+1.73%)
$SPX : 6,297.36 (+0.54%)
FTAI : 115.65 (+0.43%)
MORN : 291.06 (+0.46%)
SFM : 169.61 (+1.40%)
GS : 705.84 (-0.42%)
INSM : 104.17 (-0.40%)
VTWO : 90.52 (+1.32%)
Insmed: Q4 Earnings Snapshot

Insmed: Q4 Earnings Snapshot

INSM : 104.17 (-0.40%)
Goldman Sachs Sees High Merger Odds For This Large-Cap Biopharma In Trump 2.0 Era: Retail Has Been Alert

Insmed specializes in treatments for rare and serious diseases and is currently advancing its lead asset, brensocatib, a potential first-in-class therapy for bronchiectasis.

INSM : 104.17 (-0.40%)
1 Vanguard Index Fund to Buy to Beat the S&P 500 in 2025, According to a Wall Street Bank

Jefferies analysts have set the S&P 500 (SNPINDEX: ^GSPC) with a 2025 target of 6,000. That forecast implies about 1% downside from its current level of 6,050, which ranks among the most bearish outlooks...

PCVX : 37.37 (+2.19%)
JPM : 289.90 (+1.43%)
$SPX : 6,297.36 (+0.54%)
FTAI : 115.65 (+0.43%)
JEF : 56.32 (+2.44%)
SFM : 169.61 (+1.40%)
MLI : 85.82 (+1.04%)
GS : 705.84 (-0.42%)
INSM : 104.17 (-0.40%)
VTWO : 90.52 (+1.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Insmed is a biopharmaceutical company engaged in the development and commercialization of ARIKAYCE, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: patients with nontuberculous mycobacteria (NTM) lung infections and cystic fibrosis (CF) patients with Pseudomonas...

See More

Key Turning Points

3rd Resistance Point 108.36
2nd Resistance Point 106.86
1st Resistance Point 105.51
Last Price 104.17
1st Support Level 102.66
2nd Support Level 101.16
3rd Support Level 99.81

See More

52-Week High 106.83
Last Price 104.17
Fibonacci 61.8% 89.09
Fibonacci 50% 83.62
Fibonacci 38.2% 78.14
52-Week Low 60.40

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar